Avacta Animal Health is delighted to be exhibiting at this year’s London Vet Show (LVS), held at Olympia, London, from the 20th to the 21st of November. Visitors to Stand H43 will be able to meet the Avacta team and learn more about the benefits of the Company’s innovative SENSITEST® canine Lymphoma Blood Test (cLBT).
This unique test is the subject of an early view, open access paper – published online by Veterinary and Comparative Oncology1 – discussing the results of a blinded retrospective study using the simple, relatively non-invasive cLBT to investigate remission and recurrence of lymphoma in dogs undergoing chemotherapy. The study confirmed the test’s suitability as a cost-effective aid to monitoring lymphoma status. In addition, delegates will be able to discover the advantages of Avacta’s SENSITEST complete allergy tests, which assist in the diagnosis and management of allergies in companion animals.
Avacta is also a sponsor of the LVS Borneo Adventure competition, offering delegates the chance to win a £12,000 trip of a lifetime for two people – a 12-day working holiday to Borneo with Worldwide Veterinary Service. To enter, simply collect a stamp from each participating sponsor in your LVS passport.
To learn more about SENSITEST cLBT and SENSITEST complete allergy tests – and complete you LVS passport – visit Avacta on Stand H43.
1 I. Alexandrakis, R. Tuli, S. C. Ractliffe, S. W. Tappin, R. D. Foale, A. Roos and K. J. Slater. Utility of a multiple serum biomarker test to monitor remission status and relapse in dogs with lymphoma undergoing treatment with chemotherapy. Veterinary and Comparative Oncology. Article first published online: 15 OCT 2014 | DOI: 10.1111/vco.12123.